Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Pain 3Osteoporosis 3Breast Neoplasms 3Prostatic Neoplasms 2Lymphoma 2Leukemia 2Bone Diseases, Metabolic 2Vitamin D Deficiency 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lung Neoplasms 1Giant Cell Tumor of Bone 1Dwarfism, Pituitary 1Disease Progression 1Carcinoma, Non-Small-Cell Lung 1Arthralgia 1

Interventions

Cyclophosphamide 130Methotrexate 93fludarabine phosphate 74Cytarabine 71Vincristine 66Whole-Body Irradiation 65Mycophenolic Acid 58Dexamethasone 55Tacrolimus 49Peripheral Blood Stem Cell Transplantation 48fludarabine 47Busulfan 46pegaspargase 43Filgrastim 41Etoposide 41Doxorubicin 41Calcium Dobesilate 40Granulocyte Colony-Stimulating Factor 39Rituximab 36Cyclosporine 36Mercaptopurine 35Melphalan 33Prednisone 31merphos 28Clofarabine 26Asparaginase 26Antilymphocyte Serum 25Leucovorin 23Daunorubicin 23Thiotepa 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Calcium × Clear all
NCT00452439 2020-12-28

A Study of Actonel for the Prevention of Bone Loss

M.D. Anderson Cancer Center

Phase 3 Completed
72 enrolled 8 charts
LymphoidOther hematologic neoplasm

Bone Diseases, Metabolic, Leukemia, Lymphoma, Osteoporosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡